Company: EOI
Filing Date: 2025-01-22
Form Type: 424B5
Source: 0001193125-25-010284
Chunk: 10

Company: Eaton Vance Enhanced Equity Income Fund
Filing Date: 2025-01-22
Form: 424B5
Chunk 10
---
 issuance of Common Shares may have an adverse effect on prices in the secondary market for our Common Shares by increasing the number of Common Shares available, which may put downward pressure on the market price for our Common Shares. Shares of Common Stock of closed-endinvestment companies frequently trade at a discount from NAV. See “Prospectus Summary—Special Risk Considerations—Discount from or premium to NAV” on page 9 of the accompanying Prospectus.

The following table sets forth for the period indicated the high and low closing market prices for Common Shares on the NYSE, and the corresponding NAV per share and the premium or discount to NAV per share at which the Fund’s Common Shares were trading as of the same date. NAV is determined no less frequently than daily, generally on each day of the week that the NYSE is open for trading. See “Determination of Net Asset Value” on page 19 of the accompanying SAI for information as to the determination of the Fund’s net asset value.

4 On January 13, 2025, the last reported sale price, NAV per Common Share and percentage premium/(discount) to NAV per Common Share, were $ 20.34, $ 20.13and 1.04%, respectively. As of January 13, 2025, the Fund had 40,775,628 Common Shares outstanding and net assets of $820,798,640.

The following table provides information about our outstanding Common Shares as of January 13, 2025:

| Title of Class |     | Amount Authorized |           |     | Amount Held by the Fund or for its Account |   |     | Amount Outstanding |            |
| Common Shares  |     |                   | Unlimited |     |                                            | 0 |     |                    | 40,775,628 |

Use of Proceeds Sales of our Common Shares, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market” as defined in Rule 415 under the 1933 Act, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange. There is no guarantee that there will be any sales of our Common Shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Actual sales, if any, of our Common Shares under this Prospectus Supplement and the accompanying Prospectus may be less than as set forth below in this paragraph. In addition, the price per share of any such sale